U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07854899) titled 'Natural History Study of Advanced RCD' on Aug. 17.
Brief Summary: ECSTASI is a Natural History Study, which will be monitoring how standard of care (SoC) affect advanced rod-cone dystrophy (RCD), a type of eye disease also known as retinitis pigmentosa. No experimental, investigational or any other drug or treatment will be tested during the study.
This study collects information in 3 parts:
Part 1: retrospective health information from medical records (up to past 10 years), Part 2: prospective health information from in-person visits (up to 1 year), and Part 3: prospective health information from medical records (up to 1 year). Pa...